AMiNDR: A Month in Neurodegenerative Disease Research
The AMiNDR Team
340 episodes
9 months ago
This is a podcast made by scientists for scientists, to help you save time so you can conduct better research. For a given month, we sort the abstracts of the latest primary research articles on Alzheimer's disease into separate categories. We then summarize them for you to enjoy on the bus, on your jog, or in the lab. We hope you find our podcast useful and accessible.
All content for AMiNDR: A Month in Neurodegenerative Disease Research is the property of The AMiNDR Team and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a podcast made by scientists for scientists, to help you save time so you can conduct better research. For a given month, we sort the abstracts of the latest primary research articles on Alzheimer's disease into separate categories. We then summarize them for you to enjoy on the bus, on your jog, or in the lab. We hope you find our podcast useful and accessible.
AMiNDR: A Month in Neurodegenerative Disease Research
29 minutes 29 seconds
1 year ago
337 - Prevention & Intervention Strategies for AD
In today's episode, Naila provides an overview of 14 articles published in November 2023 on non-pharmacological interventions for AD. You'll hear about cognitive training, music therapy, chair yoga, providing support to caregivers, and a range of neural stimulation techniques. Enjoy!
Cognitive and Social Factors (2:26)
Lifestyle interventions (13:40)
Stimulation Techniques (19:20)
AMiNDR: A Month in Neurodegenerative Disease Research
This is a podcast made by scientists for scientists, to help you save time so you can conduct better research. For a given month, we sort the abstracts of the latest primary research articles on Alzheimer's disease into separate categories. We then summarize them for you to enjoy on the bus, on your jog, or in the lab. We hope you find our podcast useful and accessible.